ProfileGDS4718 / 221961_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 73% 71% 70% 71% 72% 66% 71% 71% 70% 68% 70% 71% 67% 70% 69% 71% 68% 71% 69% 83% 68% 67% 72% 68% 68% 72% 71% 71% 69% 72% 68% 67% 72% 67% 70% 66% 73% 70% 70% 71% 68% 75% 70% 68% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1411573
GSM549102patient 115, normal, homogenized [OPG study]6.924571
GSM549104patient 119, normal, homogenized [OPG study]6.9655370
GSM549108patient 138, normal, homogenized [OPG study]6.8986271
GSM549119patient 077, normal, homogenized [OPG study]7.0053772
GSM549133patient 032, cancer, homogenized [OPG study]6.5801966
GSM549139patient 042, cancer, homogenized [OPG study]6.9884571
GSM549099patient 107, normal, homogenized [OPG study]6.897171
GSM549109patient 139, normal, homogenized [OPG study]6.8178270
GSM549110patient 046, normal, homogenized [OPG study]6.6975168
GSM549114patient 063, normal, homogenized [OPG study]6.8636670
GSM549122patient 082, normal, homogenized [OPG study]6.9969371
GSM549134patient 033, cancer, homogenized [OPG study]6.655667
GSM549136patient 036, cancer, homogenized [OPG study]6.8757770
GSM549140patient 044, cancer, homogenized [OPG study]6.8191369
GSM549111patient 047, normal, homogenized [OPG study]6.953571
GSM549113patient 057, normal, homogenized [OPG study]6.6980468
GSM549132patient 031, cancer, homogenized [OPG study]6.9980171
GSM549137patient 038, cancer, homogenized [OPG study]6.8470369
GSM549142patient 047, cancer, homogenized [OPG study]7.8995783
GSM549100patient 110, normal, homogenized [OPG study]6.6933268
GSM549107patient 135, normal, homogenized [OPG study]6.6010867
GSM549115patient 068, normal, homogenized [OPG study]7.0709772
GSM549116patient 072, normal, homogenized [OPG study]6.749568
GSM549120patient 078, normal, homogenized [OPG study]6.6952568
GSM549131patient 030, cancer, homogenized [OPG study]7.1200572
GSM549118patient 074, normal, homogenized [OPG study]6.9703371
GSM549129patient 027, cancer, homogenized [OPG study]7.0579971
GSM549123patient 088, normal, homogenized [OPG study]6.7612369
GSM549124patient 006, cancer, homogenized [OPG study]7.0036672
GSM549126patient 015, cancer, homogenized [OPG study]6.7327468
GSM549128patient 025, cancer, homogenized [OPG study]6.7147967
GSM549103patient 117, normal, homogenized [OPG study]6.9991672
GSM549117patient 073, normal, homogenized [OPG study]6.5603767
GSM549138patient 041, cancer, homogenized [OPG study]6.9419470
GSM549141patient 045, cancer, homogenized [OPG study]6.6176266
GSM549130patient 028, cancer, homogenized [OPG study]7.1095873
GSM549101patient 111, normal, homogenized [OPG study]6.8941870
GSM549105patient 128, normal, homogenized [OPG study]6.8328770
GSM549106patient 134, normal, homogenized [OPG study]7.0150771
GSM549112patient 048, normal, homogenized [OPG study]6.7298868
GSM549125patient 011, cancer, homogenized [OPG study]7.3367675
GSM549127patient 024, cancer, homogenized [OPG study]6.9787170
GSM549135patient 035, cancer, homogenized [OPG study]6.7398268